Compare Lupin Ltd with Sterling Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs STERLING BIOTECH - Comparison Results

LUPIN     Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN STERLING BIOTECH LUPIN/
STERLING BIOTECH
 
P/E (TTM) x -125.2 -0.4 - View Chart
P/BV x 2.8 0.0 19,624.5% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 LUPIN   STERLING BIOTECH
EQUITY SHARE DATA
    LUPIN
Mar-19
STERLING BIOTECH
Dec-13
LUPIN/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs98611 9,390.5%   
Low Rs7203 21,188.2%   
Sales per share (Unadj.) Rs369.526.8 1,378.3%  
Earnings per share (Unadj.) Rs13.4-15.0 -89.6%  
Cash flow per share (Unadj.) Rs37.4-5.5 -684.3%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs303.754.9 553.4%  
Shares outstanding (eoy) m452.49267.87 168.9%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.30.3 890.7%   
Avg P/E ratio x63.6-0.5 -13,697.8%  
P/CF ratio (eoy) x22.8-1.3 -1,793.9%  
Price / Book Value ratio x2.80.1 2,218.4%  
Dividend payout %00-   
Avg Mkt Cap Rs m386,0641,862 20,737.2%   
No. of employees `00017.71.4 1,306.1%   
Total wages/salary Rs m31,513547 5,763.1%   
Avg. sales/employee Rs Th9,453.85,303.3 178.3%   
Avg. wages/employee Rs Th1,782.0403.8 441.3%   
Avg. net profit/employee Rs Th343.0-2,959.0 -11.6%   
INCOME DATA
Net Sales Rs m167,1827,181 2,328.2%  
Other income Rs m3,64043 8,545.1%   
Total revenues Rs m170,8227,223 2,364.9%   
Gross profit Rs m28,822947 3,043.8%  
Depreciation Rs m10,8502,543 426.6%   
Interest Rs m3,0784,377 70.3%   
Profit before tax Rs m18,534-5,931 -312.5%   
Minority Interest Rs m-890-   
Prior Period Items Rs m380-   
Extraordinary Inc (Exp) Rs m-3,4000-   
Tax Rs m9,017-1,924 -468.6%   
Profit after tax Rs m6,066-4,007 -151.4%  
Gross profit margin %17.213.2 130.7%  
Effective tax rate %48.732.4 149.9%   
Net profit margin %3.6-55.8 -6.5%  
BALANCE SHEET DATA
Current assets Rs m138,53614,335 966.4%   
Current liabilities Rs m61,29949,809 123.1%   
Net working cap to sales %46.2-494.0 -9.4%  
Current ratio x2.30.3 785.3%  
Inventory Days Days84403 20.8%  
Debtors Days Days112171 65.9%  
Net fixed assets Rs m127,51655,432 230.0%   
Share capital Rs m905268 337.8%   
"Free" reserves Rs m136,51713,935 979.7%   
Net worth Rs m137,42214,701 934.8%   
Long term debt Rs m66,4179,478 700.8%   
Total assets Rs m279,49473,988 377.8%  
Interest coverage x7.0-0.4 -1,977.9%   
Debt to equity ratio x0.50.6 75.0%  
Sales to assets ratio x0.60.1 616.3%   
Return on assets %3.30.5 653.1%  
Return on equity %4.4-27.3 -16.2%  
Return on capital %8.9-6.4 -138.6%  
Exports to sales %025.9 0.0%   
Imports to sales %00.2 0.0%   
Exports (fob) Rs mNA1,860 0.0%   
Imports (cif) Rs mNA12 0.0%   
Fx inflow Rs m59,4141,860 3,194.6%   
Fx outflow Rs m22,28225 89,521.9%   
Net fx Rs m37,1321,835 2,023.6%   
CASH FLOW
From Operations Rs m16,6601,719 969.3%  
From Investments Rs m-32,825-3,148 1,042.6%  
From Financial Activity Rs m7,4411,426 521.8%  
Net Cashflow Rs m-8,724-3 256,579.4%  

Share Holding

Indian Promoters % 46.6 33.9 137.5%  
Foreign collaborators % 0.2 0.0 -  
Indian inst/Mut Fund % 11.3 0.0 -  
FIIs % 31.9 9.9 322.2%  
ADR/GDR % 0.0 16.9 -  
Free float % 10.1 39.3 25.7%  
Shareholders   98,259 21,482 457.4%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   VENUS REMEDIES  ORCHID PHARMA LTD  SANOFI INDIA  J.B.CHEMICALS  SHASUN PHARMA  

Compare LUPIN With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Zooms 879 Points; Consumer Durables and Metal Stocks Rally(Closing)

Extending gains to the fourth consecutive day, Indian share markets witnessed buying interest throughout the day and ended on a strong note.

Related Views on News

LUPIN Announces Quarterly Results (4QFY20); Net Profit Up 35.5% (Quarterly Result Update)

Jun 1, 2020 | Updated on Jun 1, 2020

For the quarter ended March 2020, LUPIN has posted a net profit of Rs 4 bn (up 35.5% YoY). Sales on the other hand came in at Rs 38 bn (down 12.7% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN Announces Quarterly Results (2QFY20); Net Profit Down 146.4% (Quarterly Result Update)

Nov 7, 2019 | Updated on Nov 7, 2019

For the quarter ended September 2019, LUPIN has posted a net profit of Rs 1 bn (down 146.4% YoY). Sales on the other hand came in at Rs 44 bn (up 10.3% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN Announces Quarterly Results (1QFY20); Net Profit Up 49.3% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, LUPIN has posted a net profit of Rs 3 bn (up 49.3% YoY). Sales on the other hand came in at Rs 44 bn (up 14.6% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of LUPIN for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

LUPIN Announces Quarterly Results (4QFY19); Net Profit Down 1.5% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, LUPIN has posted a net profit of Rs 3 bn (down 1.5% YoY). Sales on the other hand came in at Rs 44 bn (up 77.8% YoY). Read on for a complete analysis of LUPIN's quarterly results.

More Views on News

Most Popular

6 Charts Showing the State of Indian Financial Markets in 2020(Sector Info)

May 26, 2020

Six charts showing how Indian financial markets have performed in 2020 so far...

This 'Essential Product' Smallcap is a Must Have for a 'Covid-19' Immune Portfolio(Profit Hunter)

May 19, 2020

This smallcap company needs no stimulus measures to do well in the long term.

What the RBI's Rate Cut Means for Options Traders(Fast Profits Daily)

May 25, 2020

The RBI governor has cut the repo rate to 4%. What does this mean for options traders? Find out in this video.

Which Stocks Should You Buy, Sell, and Hold in the Market Today?(Profit Hunter)

May 21, 2020

The coronavirus led uncertainty refuses to go away from the markets. Here's what retail investors should do with their stocks...

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN SHARE PRICE


Jun 1, 2020 (Close)

TRACK LUPIN

COMPARE LUPIN WITH

MARKET STATS